Thymoquinone (TQ) acts as an important radio‐sensitizer in breast cancer therapy by reducing radiation‐induced toxicity and invasion while inhibiting metastatic progression driven by TGF‐β signaling [168]. Here, TGFB1 is linked to breast carcinoma.